Romagnani S, Biliotti G, Ricci M
Clin Exp Immunol. 1975 Jan;19(1):83-91.
Serum from grass-sensitive patients who had received hyposensitization therapy was found able to depress the in vitro response to Holcus lanatus grass pollen extract of lymphocytes from untreated grass-sensitive individuals. The inhibitory activity could no longer be demonstrated at serum dilutions equal to or greater than 1/100 and was not seen when the cells were stimulated with PHA or unrelated antigens. It was contained in the precipitated fraction of 33% saturated ammonium sulphate-treated serum, segregated with the 7S peak of Sephadex G-200 and with the IgG fraction of DEAE-Sephadex-fractionated serum and could be removed by the absorption of the serum with the Holcus lanatus allergenic extract. These data suggest that the serum factor responsible for the depressed in vitro lymphocyte response to the allergen in hyposensitized patients was a 7S IgG antibody induced by immunotherapy.
研究发现,接受过脱敏治疗的对草过敏患者的血清,能够抑制未经治疗的对草过敏个体的淋巴细胞对绒毛草花粉提取物的体外反应。当血清稀释度等于或大于1/100时,这种抑制活性就不再能被检测到;并且当细胞受到PHA或无关抗原刺激时,也不会出现这种抑制活性。它存在于经33%饱和度硫酸铵处理的血清的沉淀部分,与Sephadex G - 200的7S峰以及DEAE - Sephadex分级分离血清的IgG部分一起分离,并且可以通过用绒毛草变应原提取物吸收血清将其去除。这些数据表明,在脱敏患者中,导致体外淋巴细胞对变应原反应降低的血清因子是免疫治疗诱导产生的一种7S IgG抗体。